The syndrome associated with the withdrawal of beta-adrenergic receptor blocking drugs.

The syndrome associated with the withdrawal of beta-adrenergic receptor blocking drugs.

Item
http://www.wikidata.org/entity/Q40087534
Labetalol: a review of its pharmacology, pharmacokinetics, clinical uses and adverse effectsTreatment of endocrine diseases.Clinical pharmacology, physiology and pathophysiology of superficial veins--2Withdrawal syndrome following cessation of antihypertensive drug therapy.The effect of intrinsic sympathomimetic activity on beta-receptor responsiveness after beta-adrenoceptor blockade withdrawal.Patients compliance in hypertension--the importance of number of tablets.Effect of β-Adrenergic Antagonists on In-Hospital Mortality after Ischemic Stroke.Beta-adrenoceptor partial agonists: a renaissance in cardiovascular therapy?Pindolol--a beta-adrenoceptor blocking drug with partial agonist activity: clinical pharmacological considerations.Penbutolol in the treatment of mild to moderate essential hypertension in black South Africans.
P2860

The syndrome associated with the withdrawal of beta-adrenergic receptor blocking drugs.

Item
http://www.wikidata.org/entity/Q40087534
description
1982 nî lūn-bûn
@nan
1982年の論文
@ja
1982年論文
@yue
1982年論文
@zh-hant
1982年論文
@zh-hk
1982年論文
@zh-mo
1982年論文
@zh-tw
1982年论文
@wuu
1982年论文
@zh
1982年论文
@zh-cn
name
The syndrome associated with the withdrawal of beta-adrenergic receptor blocking drugs.
@en
type
label
The syndrome associated with the withdrawal of beta-adrenergic receptor blocking drugs.
@en
prefLabel
The syndrome associated with the withdrawal of beta-adrenergic receptor blocking drugs.
@en
P1433
P1476
P2093
P2860
P304
P31
P356
P407
P433
P478
P577
P5875
P698
P932
P356
P1433
P1476
The syndrome associated with the withdrawal of beta-adrenergic receptor blocking drugs.
@en
P2093
P2860
P304
P31
P356
10.1111/J.1365-2125.1982.TB01938.X
P407
P433
P478
P577
P5875
P698
P932